Breast MRI May Be Safely Omitted From Diagnostic Workup in Certain Patients With Early-stage, HR-negative Breast Cancer
Preoperative MRI had no impact on five-year recurrence rates SAN ANTONIO – Patients with stage 1 or 2, hormone...
Search/Filter
Loading...
Sentinel Lymph Node Biopsy May Be Safely Omitted in Some Patients With Early-stage Breast Cancer
Omission of sentinel lymph node biopsy did not change five-year recurrence rates SAN ANTONIO – Skipping sentinel lymph node...
A Multimodal AI Model May Improve Recurrence Risk Stratification in Early Breast Cancer
New model provided better prognostic information for recurrence in HR-positive, HER2-negative breast cancer than the Oncotype DX 21-gene recurrence...
Sacituzumab Govitecan-hziy Led to Similar Progression-free Survival as Standard of Care for Certain Endocrine Therapy-refractory Advanced Breast Cancers
SAN ANTONIO – Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they...
Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial
Benefit was seen across all subgroups, including in patients with brain metastasis SAN ANTONIO – Adding tucatinib (Tukysa) to...
Novel Endocrine Therapy Giredestrant Improves Disease-free Survival Over Standard of Care for Patients With Early-stage Breast Cancer in Phase III lidERA Trial
SAN ANTONIO – The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant...
AACR Releases Inaugural Pediatric Cancer Progress Report
More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has...
AACR Project GENIE Named a Winner of the 2025 Amazon Web Services Imagine Grant for Nonprofits
AI-powered, multilingual cancer research pipeline will accelerate the pace of global data curation and expand access to real-world clinical...
Award Recipients Announced for the 2025 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an SABCS cosponsor, will honor...
AACR Applauds Selection of Richard Pazdur, MD, as Director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Richard Pazdur, MD, on his appointment as Director...